BMSN/BIO-MATRIX SCIENTIFIC GROUP INC: ONE CATCHY STOCK!
There has been a spectacular rise in the Bio-Matrix Scientific Group, Inc to over a penny from triple zero twos. The stock continues to explode massively and the speculators predict that this would rise further.
Regen BioPharma is BSMN’s subsidiary which has formulated HemaXellerate I™ which is a new stem cell drug to fight Aplastic Anemia. It is due to the introduction of this drug that the stock of BSMN is so excited. BSMN has submitted an investigational New Drug (IND) application to the FDA and by the look of it, things are going up.
HemaXellerate I™ would combat Aplastic Anemia. It is a stem cell drug which is eligible for Orphan Drug status. This makes HemaXellerate I™ fully approvable by the FDA in within 60 days to bypass an extensive Phase I, II, III, IV of FDA approval procedure.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.